|POZEN Announces August 5 Webcast of Second-Quarter Results|
CHAPEL HILL, N.C.--(BUSINESS WIRE)--July 30, 2003--POZEN Inc. (NASDAQ:POZN), a pharmaceutical company developing therapeutic advancements in a cost effective manner, today announced it will host a conference call following the release of financial results for the second quarter ended June 30, 2003. The company will release results before the market opens on Tuesday, August 5, 2003. John R. Plachetka, Pharm.D., POZEN's chairman, president and chief executive officer, and Matthew E. Czajkowski, chief financial officer, will host the conference call the same day at 11:00 a.m. Eastern time.
The conference call will be simulcast live on the Internet, and can be accessed by logging on to www.pozen.com. A replay will be available for seven days in the Investor Relations section of the company's website. POZEN's second quarter results release can be accessed in the News section of www.pozen.com and by clicking on the release dated August 5, 2003.
POZEN is a pharmaceutical company developing therapeutic advancements in a cost effective manner. Since its inception, POZEN has developed the largest and most advanced product pipeline in the field of migraine. Product development efforts are focused on diseases with unmet medical needs where POZEN can improve efficacy, safety, and/or patient convenience. The company's common stock is traded on The Nasdaq Stock Market under the symbol "POZN."